APTA Therapeutics welcomes Dr. Daniel Bock as Chief Scientific Officer / Chief Operational Officer
APTA Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative therapies for diseases associated with regulatory autoantibodies, strengthens its management team.